Search results
Results From The WOW.Com Content Network
Narrow-spectrum antibiotics have low propensity to induce bacterial resistance and are less likely to disrupt the microbiome (normal microflora). [3] On the other hand, indiscriminate use of broad-spectrum antibiotics may not only induce the development of bacterial resistance and promote the emergency of multidrug-resistant organisms, but also cause off-target effects due to dysbiosis.
A colored electron microscopy image of methicillin-resistant staphylococcus aureus (), a bacterium commonly targeted by broad-spectrum antibioticsA broad-spectrum antibiotic is an antibiotic that acts on the two major bacterial groups, Gram-positive and Gram-negative, [1] or any antibiotic that acts against a wide range of disease-causing bacteria. [2]
Often, the exact species of bacteria causing the illness is unknown, in which case narrow-spectrum antibiotics can't be used, and broad-spectrum antibiotics are used instead. To know the exact species of bacteria causing the illness, clinical specimens need to be taken for antimicrobial susceptibility testing in a clinical microbiology laboratory.
The following is a list of antibiotics. ... negative organisms and therefore useful for empiric broad-spectrum antibacterial coverage. ... more narrow-spectrum than ...
This involves the administration of a broad-spectrum antibiotic based on the signs and symptoms presented and is initiated pending laboratory results that can take several days. [34] [35] When the responsible pathogenic microorganism is already known or has been identified, definitive therapy can be started. This will usually involve the use of ...
β-Lactam antibiotics are indicated for the prevention and treatment of bacterial infections caused by susceptible organisms. At first, β-lactam antibiotics were mainly active only against gram-positive bacteria, yet the recent development of broad-spectrum β-lactam antibiotics active against various gram-negative organisms has increased their usefulness.
However, de la Fuente says this method of modifying molecules to target a specific bacteria could be better for our overall health, as many broad-spectrum antibiotics are known to kill good ...
Sarecycline is a narrow-spectrum antibiotic. [56] [57] Omadacycline: 16+ hours (long) (formerly known as PTK-0796 [58]) received FDA approval on October 2, 2018, for treatment of community-acquired pneumonia [59] and acute skin and skin structure infections. [60]